VISCHER advised Versameb in its CHF 6 million seed financing round

Versameba preclinical-stage biopharmaceutical company located in Basel, has closed a CHF 6 million seed financing round. Versameb is engaged in the discovery and development of next-generation RNA-based drugs using its proprietary VERSagile technology platform developing molecules targeting regulation of immune response or regeneration in the fields of dermatology, oncology and myology.

The advisor

VISCHER advises Versameb in this transaction. The team included partner Matthias Staehelin (pictured), managing associates Moritz Jäggy and Dania Salvisberg-Schneider (all Corporate).

VISCHER advised Versameb in its CHF 6 million seed financing round


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram